SLTM  Solta Medical Inc

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

235.8M

Vuru Grade

22.38/100

Current Price

$2.92
0.00 (0.00%)

Growth Price

$2.04
Overvalued by 30.20%

Stability Price

$0.56
Overvalued by 80.81%

Company Metrics

  • 162.22 P/E
  • 1.56 P/S
  • 1.71 P/B
  • 0 EPS
  • 14.17% Cash ROIC
  • 0.51 Cash Ratio
  • 0 / 0% Dividend
  • 1.50M Avg. Vol.
  • 60.57M Shares
  • 235.8M Market Cap.

Company Description

Solta Medical, Inc. designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications. Its products include Thermage NXT and CPT systems that provide non-invasive treatment options for skin tightening and contouring, body shaping, and enhancement in the appearance of cellulite; Fraxel re:fine and Fraxel re:store systems, which offer treatments for skin con...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Solta Medical Inc (SLTM): Zeltiq Aesthetics And Solta Medical Are Likely In Play
Seeking Alpha - Nov 14, 2013
Solta Medical (SLTM) announced on Monday of this week that it has hired Piper Jaffray as its investment banker/financial advisor to potentially explore a sale of the company. We estimate that the company has been in a black-out period for about seven ...
Solta Medical explores sale after loss exceeds estimate
Reuters - Nov 12, 2013
(Reuters) - Solta Medical Inc SLTM.O is exploring a sale due to falling profits from its medical equipment to remove fat and improve the appearance of a person's skin and pressure from activist investor Voce Capital Management LLC.
Solta Medical to evaluate strategic alternatives - MarketWatch
Solta Medical Reports Third Quarter 2013 Results and Actions Implemented to ... - PR Newswire (press release)
Valeant Acquires Solta Medical
Zacks.com - Dec 17, 2013
Valeant Pharmaceuticals International, Inc. (VRX - Analyst Report) has entered into a definitive agreement to acquire all of the outstanding common stock of Solta Medical, Inc. for $2.92 per share in cash or $250 million. The offer price of $2.92 per ...
Acquisition of Solta Medical, Inc. by Valeant Pharmaceuticals International ... - PR Newswire (press release)
Valeant strikes deal to buy US-based Solta Medical - The Globe and Mail
Solta Medical Inc (SLTM): Is An Acquisition Of Solta Medical Imminent?
Seeking Alpha - Sep 25, 2013
It is in the best interest of shareholders to explore the potential sale of Solta Medical, Inc. Companies that are looking to make acquisitions through full or partial methods of debt financing are extremely aware of the changing economic climate and ...
Solta Medical Inc (SLTM): Solta Medical Agrees To Be Acquired By Valeant, But ...
Seeking Alpha - Dec 23, 2013
On Monday, December 16th, Valeant (NYSE:VRX) submitted what for the time being, is the winning bid to acquire Solta Medical Devices (NASDAQ:SLTM). For some time now, we have been predicting that Solta would be acquired before the end of this year.
Solta Medical Agrees To Be Acquired By Valeant, But Another Bid Might Emerge - Trefis
Solta Medical CEO steps down as company revamps sales strategy
San Francisco Business Times (blog) - Aug 6, 2013
Under Fanning, Solta was a major acquirer as the medical aesthetics industry grew and matured. Besides Sound Surgical, the company bought acne treatment company CLRS Technology, Reliant Technologies Inc. and Pleasanton's Aesthera Corp., but it has ...
Solta Medical Inc (SLTM): Solta Medical Officially Hires An Investment Banker ...
Seeking Alpha - Nov 12, 2013
In the on-going saga of Solta Medical (NASDAQ:SLTM), the next chapter has been written, when on the company's earnings call yesterday it announced it has hired Piper Jaffray as its financial advisor/investment banker to explore strategic alternatives.
Solta Medical Inc (SLTM): Voce Capital Pushes For Acquisition Of Solta Medical ...
Seeking Alpha - Aug 9, 2013
Written by Scott Matusow. Scott has a position in the company featured in this article. Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market.
Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David ... - Trefis
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta ...
MarketWatch - Jan 23, 2014
... Pharmaceuticals International, Inc. ("Valeant") today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International ("VPI") would acquire Solta Medical, Inc. SLTM ...
Solta Medical Inc : Valeant looking for a big acquisition to help it become ...
4-traders (press release) - Jan 7, 2014
Valeant announced a deal valued at US$250 million a few weeks ago to buy California -based Solta Medical Inc. , a company that makes medical devices for skin tightening, body contouring and treating inflammatory acne, for example.
Why Valeant Pharmaceuticals Intl. Inc. Shares Popped - Motley Fool